Tuesday 7-8-2014 Pure Bioscience (PURE) $PURE open

Tuesday 7-8-2014 Pure Bioscience (PURE) $PURE opened at 1.0300 hitting the high price of 1.0600 and a day low of 1.0300 with a total volume of 42,629. PURE had a previous close of 1.0700 and has been seeing an average volume of 47,541.

Overall Average: 72% Sell

Recent stock forum discussions about PURE http://investorshangout.com/search?q=PURE&...mp;yt0=Go!

PURE Bioscience posts higher net loss of USD2.1m for Q3 fiscal 2014
M2 - Wed Jun 11, 5:57AM CDT
Antimicrobial company PURE Bioscience (OTCQB URE) disclosed on Tuesday its net loss of USD2.1m for the third fiscal quarter of 2014. (full story)

PURE Bioscience Reports Fiscal Third Quarter 2014 Financial Results
Marketwire - Tue Jun 10, 3:04PM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the second fiscal quarter ended April 30, 2014. (full story)

PURE Creates Market Development Team Focused on Direct Food Contact Application
Marketwire - Fri Jun 06, 7:32AM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that Bridget Tinsley joined PURE in the newly created position of Vice President Market Development. Tinsley will be responsible for both expanding the market for SDC as a food contact surface disinfectant and sanitizer and leading the future commercial applications of SDC as a food safety aid in the processing of poultry, meat and produce. Tinsley has nearly fifteen years of food industry and food safety experience with diverse expertise across global food programs, territory sales, account management, and laboratory research and business development. (full story)

PURE Bioscience to Host Q3 Investor Conference Call June 10th, 2014 and Review Progress of SDC-Based Food Safety Solutions Strategy
Marketwire - Thu Jun 05, 1:57AM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that the Company will host an investor conference call on Tuesday, June 10th, 2014 at 1:30pm PDT (4:30pm EDT). (full story)

PURE Bioscience to Present at LD Micro Invitational on June 4th
Marketwire - Tue May 27, 7:36AM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that Hank R. Lambert, CEO, will present at the LD MICRO Invitational at the Luxe Sunset, Los Angeles, on Wednesday, June 4th, 2014 at 1:30pm PDT. (full story)

PURE Bioscience to Present at Marcum Third Annual Micro Cap Conference
PR Newswire - Tue May 20, 7:41AM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that Peter C. Wulff, CFO & COO, will present at the Marcum Third Annual Micro Cap Conference on Thursday, May 29, at 1:30pm EDT, at the Grand Hyatt New York. (full story)

PURE Bioscience Initiates SDC Antimicrobial Testing With Three Additional National QSR Chains
Marketwire - Mon May 19, 7:34AM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that it has initiated testing of PURE(R) Hard Surface disinfectant and sanitizer in three additional national Quick Service Restaurant (QSR) chains. Also, the Company announced that it had smoothly completed the regional supply chain and distribution rollout to 650 units of a leading QSR chain, resulting in positive initial customer feedback on PURE Hard Surface. (full story)

PURE's SDC-Based Antimicrobial Dramatically Reduces Salmonella in Processed Poultry Testing
Marketwire - Thu May 01, 7:34AM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced the successful completion of testing of SDC as a processing aid and intervention in the processing of poultry. The testing demonstrated a materially significant reduction in salmonella contamination, representing a substantial food safety enhancement to current poultry processing. The Company is preparing for submission to the USDA and FDA, seeking regulatory approval for use of SDC in direct food contact as a processing aid for poultry. (full story)

PURE Bioscience Reports Fiscal Second Quarter 2014 Financial Results
Marketwire - Thu Mar 13, 3:02PM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the second fiscal quarter ended January 31, 2014. (full story)

PURE Bioscience Hosts Q2 Results Conference Call March 13th, 2014 and Reviews Progress of SDC-Based Food Safety Solutions Strategy
Marketwire - Mon Mar 03, 7:30AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that the Company will host an investor conference call on Thursday, March 13th, 2014 at 1:30pm PDT (4:30pm EDT). (full story)

PURE Bioscience Business Update and Goals -- Food Safety Strategy Gaining Traction
Marketwire - Thu Jan 30, 7:30AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced that execution of its Food Safety Solutions Strategy continues to progress. The Company also announced its goals for calendar year 2014. (full story)

PURE Developing SDC-Based Antimicrobial for Direct Food Application
Marketwire - Tue Jan 28, 7:31AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced progress in development of a SDC-based antimicrobial for direct food contact. The Company is testing formulations to be used as a rinse or processing aid on produce, poultry, and meats. (full story)

PURE Completes Phase One Technology Transfer for Expanded Production -- Intercon SDC Facility Online
Marketwire - Thu Jan 23, 7:30AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced it has completed the first phase of the SDC technology transfer to its collaboration partner, Intercon Chemical Company (ICC). The first phase consists of the partial transfer of PURE's unique and proprietary SDC manufacturing process into a new and dedicated production facility at ICC's St. Louis manufacturing location. (full story)

PURE's SDC-Based Food Safety Solutions Strategy Gains Traction -- Initial Orders From Three Food Processors
Marketwire - Thu Jan 16, 7:30AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced continued progress on its strategic positioning as a food safety solution which was launched this past Fall. (full story)

5W Public Relations Expands Corporate Practice, Adds PURE Bioscience, Inc. to Client Roster
PR Newswire - Wed Dec 18, 7:45AM CST
5W Public Relations, one of the 25 largest independent public relations firms in the U.S., announced the addition of PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial agent, to its diverse roster of corporate clients. (full story)

PURE Bioscience Reports Fiscal First Quarter 2014 Financial Results
Marketwire - Thu Dec 12, 3:05PM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal first quarter ended October 31, 2013 (Fiscal Q1 2014). (full story)

PURE Announces Strategic Collaboration With Intercon Chemical Company
Marketwire - Thu Dec 12, 7:30AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced it has entered into a five-year strategic collaboration agreement with St. Louis-based Intercon Chemical Company (ICC). The agreement consists of a multi-pronged approach to accelerate the commercialization of PURE's unique and proprietary SDC-based products. (full story)

PURE Bioscience Appoints New CEO
Marketwire - Tue Sep 10, 7:30AM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced the appointment of Hank Lambert as its new Chief Executive Officer. Mr. Lambert replaces the interim CEO, Dave Pfanzelter, who remains as Chairman of the Board. The company reported that the management change is part of its previously announced reorganization establishing new and experienced leadership focused on commercialization of SDC technology in the food industry as a unique and proprietary antimicrobial agent to protect consumer safety against various pathogens. (full story)

PURE Bioscience expands sales and marketing team with addition of Cliff Wechsler & Tom Myers
M2 - Thu Aug 29, 4:35AM CDT
Antimicrobial company PURE Bioscience (OTCQB URE) said on Wednesday that it is strengthening of its sales and marketing leadership team to drive the commercialisation of SDC technology to protect consumer safety against various pathogens in the food industry. (full story)

PURE Bioscience Strengthens Sales and Marketing Organization
Marketwire - Wed Aug 28, 7:30AM CDT
PURE Bioscience (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced the strengthening of its sales and marketing leadership team. The company appointed Cliff Wechsler as its new Executive Vice President of Sales, and Tom Myers assumed the position of Executive Vice President of Marketing and Product Development. The company reported that the management change established the leadership to drive the commercialization of SDC technology in the food industry as a novel and proprietary antimicrobial agent to protect consumer safety against various pathogens. (full story)